Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Mumbai Centre for International Arbitration set to host MCIA Singapore Roadshow at the Singapore Convention Week

SILF holds Sindoor Meeting at Pahalgam, resolves to support families affected by Pahalgam attack

Clarence & Partners advises investor Visceral on Mythik's ~₹128 crore fundraise

Service charge on top of ₹100 rupee water bottle? Delhi High Court miffed

Novelty in the age of algorithms

SCROLL FOR NEXT